MTOR and cancer: For instance tumor-associated immune cells, fibroblasts, and cancer cells can all secrete soluble signaling factors (e.g., cytokines and growth factors) that can activate cancer cell signaling pathways in autocrine or paracrine fashion to induce drug resistance (mTOR, NF-κB, AKT, STAT3)[10-12].